Sonoma Pharmaceuticals Welcomes New Member of its Board of Directors and New Senior Vice President of Regulatory, Quality and Product Development

Core Viewpoint - Sonoma Pharmaceuticals, Inc. has appointed Vanessa Jacoby to its Board of Directors and as Chair of its Audit Committee, while announcing the retirement of Dr. Jay Birnbaum [1] Group 1: Company Developments - Vanessa Jacoby, previously Chief Business and Financial Officer of Quanta Therapeutics, Inc., joins Sonoma Pharmaceuticals' Board of Directors [1] - The company has announced the retirement of longtime director Dr. Jay Birnbaum [1] Group 2: Product and Technology - Sonoma Pharmaceuticals specializes in developing and producing patented Microcyn® technology based stabilized hypochlorous acid (HOCl) products for various applications [1] - The applications of Sonoma's products include wound care, eye care, dermatological conditions, podiatry, and animal health care [1]